Lykos Therapeutics filed an application for FDA approval of its version of MDMA-assisted therapy for PTSD in February 2024.

MARINE VET TOUTS BENEFITS OF PSYCHEDELIC-ASSISTED PTSD DRUGS AS FDA CONSIDERS MDMA APPROVAL "MDMA allows people to access parts of their trauma that are deeply seated that they've not been able to ...

A Food and Drug Administration (FDA) advisory panel overwhelmingly rejected MDMA-assisted therapy for treating post-traumatic ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) ...

The FDA was following the recommendation of an advisory panel that had expressed several concerns about two Phase 3 studies ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

Amy Emerson is stepping down on the heels of the FDA last month rejecting Lykos Therapeutics’ MDMA-based therapy for ...

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the ...

As Psychiatric Times reported, this decision puts on hold what could have been a landmark approval for the treatment of PTSD with MDMA, also known as midomafetamine. Despite the setback, Lykos ...

Dr. Rachel Yehuda has been studying trauma for decades, and now she’s spearheading clinical research on MDMA-assisted therapy ...

Delve into the psychedelic-assisted therapy market and investors' sentiment after the FDA's decision about Lykos' MDMA ...